Reserach canakinumab trial UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm

A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital. The Phase III, […]